The U.S. National Institute of Allergy and Infectious Diseases announced that it will pay for a series of drug tests to ascertain the effectiveness of a ring that has proven to protect women from HIV infection. Prior studies of the ring in Africa have shown that the risk of infection fell 61 percent in women age 25 and older who used the ring, and 27 percent on average across the study’s whole. “If you could get a 61 percent efficacy in the older group, that means there is something about this that works,” institute director Dr. Anthony Fauci told NBC News.
Researchers found via blood testing that younger women are more likely to remove the ring. The vaginal insert is meant to be placed once a month to release the anti-HIV medicine dapirivine into a woman’s body. In the United States, more than 1.2 million people have HIV, and about 50,000 people are newly infected each year.
Read the full story at NBC News.